CN102526797B - Preparation method of high-strength biological glass bone bracket with regular-hole distribution - Google Patents
Preparation method of high-strength biological glass bone bracket with regular-hole distribution Download PDFInfo
- Publication number
- CN102526797B CN102526797B CN 201210026907 CN201210026907A CN102526797B CN 102526797 B CN102526797 B CN 102526797B CN 201210026907 CN201210026907 CN 201210026907 CN 201210026907 A CN201210026907 A CN 201210026907A CN 102526797 B CN102526797 B CN 102526797B
- Authority
- CN
- China
- Prior art keywords
- glass
- slurry
- preparation
- scaffold
- bone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000011521 glass Substances 0.000 title claims abstract description 59
- 210000000988 bone and bone Anatomy 0.000 title claims abstract description 34
- 238000002360 preparation method Methods 0.000 title claims abstract description 27
- 238000009826 distribution Methods 0.000 title claims abstract description 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims abstract description 36
- 238000000034 method Methods 0.000 claims abstract description 36
- 239000002002 slurry Substances 0.000 claims abstract description 32
- 239000000843 powder Substances 0.000 claims abstract description 18
- 239000004721 Polyphenylene oxide Substances 0.000 claims abstract description 14
- 229920000570 polyether Polymers 0.000 claims abstract description 14
- 238000002156 mixing Methods 0.000 claims abstract description 12
- 239000007788 liquid Substances 0.000 claims abstract description 10
- 230000008569 process Effects 0.000 claims abstract description 10
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 claims abstract description 3
- 239000011148 porous material Substances 0.000 claims description 18
- 239000000463 material Substances 0.000 claims description 17
- 239000000203 mixture Substances 0.000 claims description 14
- 239000000243 solution Substances 0.000 claims description 12
- 239000005312 bioglass Substances 0.000 claims description 11
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 9
- 238000005245 sintering Methods 0.000 claims description 9
- 230000007704 transition Effects 0.000 claims description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
- 239000007787 solid Substances 0.000 claims description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 6
- 239000003054 catalyst Substances 0.000 claims description 6
- 238000002347 injection Methods 0.000 claims description 6
- 239000007924 injection Substances 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 229910018072 Al 2 O 3 Inorganic materials 0.000 claims description 5
- 239000003350 kerosene Substances 0.000 claims description 5
- 238000007639 printing Methods 0.000 claims description 5
- 239000000376 reactant Substances 0.000 claims description 5
- 239000000725 suspension Substances 0.000 claims description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 4
- 229910000287 alkaline earth metal oxide Inorganic materials 0.000 claims description 4
- 238000001125 extrusion Methods 0.000 claims description 4
- 230000008439 repair process Effects 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 claims description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 3
- HDEPFLVKWKPGFZ-UHFFFAOYSA-N Cl(=O)(=O)O.[Pt] Chemical compound Cl(=O)(=O)O.[Pt] HDEPFLVKWKPGFZ-UHFFFAOYSA-N 0.000 claims description 3
- 235000010354 butylated hydroxytoluene Nutrition 0.000 claims description 3
- 229910052791 calcium Inorganic materials 0.000 claims description 3
- 239000011575 calcium Substances 0.000 claims description 3
- 150000002500 ions Chemical class 0.000 claims description 3
- 229910052757 nitrogen Inorganic materials 0.000 claims description 3
- 239000002245 particle Substances 0.000 claims description 3
- 238000010992 reflux Methods 0.000 claims description 3
- 229910019142 PO4 Inorganic materials 0.000 claims description 2
- 229910004298 SiO 2 Inorganic materials 0.000 claims description 2
- 229910000272 alkali metal oxide Inorganic materials 0.000 claims description 2
- 238000004590 computer program Methods 0.000 claims description 2
- 239000006066 glass batch Substances 0.000 claims description 2
- 229910044991 metal oxide Inorganic materials 0.000 claims description 2
- 150000004706 metal oxides Chemical class 0.000 claims description 2
- 239000000178 monomer Substances 0.000 claims description 2
- 229920000642 polymer Polymers 0.000 claims description 2
- 239000002994 raw material Substances 0.000 claims description 2
- 239000000377 silicon dioxide Substances 0.000 claims description 2
- 235000012239 silicon dioxide Nutrition 0.000 claims description 2
- 238000007711 solidification Methods 0.000 claims description 2
- 230000008023 solidification Effects 0.000 claims description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims 1
- 229910052681 coesite Inorganic materials 0.000 claims 1
- 229910052906 cristobalite Inorganic materials 0.000 claims 1
- 238000004821 distillation Methods 0.000 claims 1
- 230000002431 foraging effect Effects 0.000 claims 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims 1
- 239000010452 phosphate Substances 0.000 claims 1
- 229910052682 stishovite Inorganic materials 0.000 claims 1
- 229910052905 tridymite Inorganic materials 0.000 claims 1
- 230000004071 biological effect Effects 0.000 abstract description 5
- 238000010146 3D printing Methods 0.000 abstract description 4
- 239000002243 precursor Substances 0.000 abstract description 2
- 239000005313 bioactive glass Substances 0.000 abstract 1
- 238000002844 melting Methods 0.000 abstract 1
- 230000008018 melting Effects 0.000 abstract 1
- 238000010298 pulverizing process Methods 0.000 abstract 1
- 238000007873 sieving Methods 0.000 abstract 1
- 238000002474 experimental method Methods 0.000 description 8
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 6
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 5
- 230000021164 cell adhesion Effects 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 4
- 230000007547 defect Effects 0.000 description 4
- 210000000963 osteoblast Anatomy 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 239000005325 borate based bioglass Substances 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 238000001157 Fourier transform infrared spectrum Methods 0.000 description 2
- 238000002441 X-ray diffraction Methods 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000005385 borate glass Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 238000005470 impregnation Methods 0.000 description 2
- 239000006193 liquid solution Substances 0.000 description 2
- 230000011164 ossification Effects 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000017423 tissue regeneration Effects 0.000 description 2
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 238000006065 biodegradation reaction Methods 0.000 description 1
- 230000033558 biomineral tissue development Effects 0.000 description 1
- 210000002449 bone cell Anatomy 0.000 description 1
- 230000008468 bone growth Effects 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- BDAGIHXWWSANSR-NJFSPNSNSA-N hydroxyformaldehyde Chemical compound O[14CH]=O BDAGIHXWWSANSR-NJFSPNSNSA-N 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000007769 metal material Substances 0.000 description 1
- 238000011587 new zealand white rabbit Methods 0.000 description 1
- 238000010534 nucleophilic substitution reaction Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 229910001404 rare earth metal oxide Inorganic materials 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
- 229910000018 strontium carbonate Inorganic materials 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000012876 topography Methods 0.000 description 1
- 238000005292 vacuum distillation Methods 0.000 description 1
Images
Landscapes
- Materials For Medical Uses (AREA)
Abstract
本发明属于生物工程技术领域,具体涉及一种有规则孔分布的高强度生物玻璃骨支架的制备方法。这种具有生物活性能完全降解的玻璃支架,制备方法包括如下步骤:用熔融法制备硼酸盐生物活性玻璃,将玻璃块粉碎、筛分成一定尺寸的玻璃粉末;将该玻璃粉体与有机调和液丙二醇嵌段聚醚溶液,调配成均匀浆体;通过计算机三维打印过程,在已经设计好的程序下打印出支架前驱体(坯体);将坯体干燥后,在高温下将其烧结,最终得到的玻璃支架不仅具有优良的生物活性。
The invention belongs to the technical field of bioengineering, and in particular relates to a preparation method of a high-strength biological glass bone bracket with regular hole distribution. The preparation method of the glass bracket with bioactivity and complete degradability includes the following steps: preparing borate bioactive glass by melting method, pulverizing and sieving the glass block into glass powder of a certain size; mixing the glass powder with organic The liquid propylene glycol block polyether solution is prepared into a uniform slurry; through the computer three-dimensional printing process, the scaffold precursor (green body) is printed out under the designed program; after the green body is dried, it is sintered at high temperature, The resulting glass scaffold not only has excellent biological activity.
Description
技术领域 technical field
本发明属于生物工程技术领域,具体涉及一种有规则孔分布的高强度生物玻璃骨支架的制备方法。 The invention belongs to the technical field of bioengineering, and in particular relates to a preparation method of a high-strength biological glass bone bracket with regular hole distribution.
背景技术 Background technique
支架作为一种为细胞的生长临时搭建一个结构,是能诱导细胞分化再生出与支架形状的相似的组织器官的场所,在骨组织工程中有着重要的作用。骨组织最大的特点是细胞间质具有大量的钙盐沉积形成人体中最硬的组织之一,结构上羟基磷灰石可看作受压材料。对于骨组织工程中的支架材料来说,首要要求的就是力学性能,即支架的力学性能必须与环境组织的力学性能相匹配:强度低的支架不足以支撑人体的日常活动需求。目前制备支架的方法主要有有机泡沫浸渍法、造孔剂法、气体发泡法和热诱发相分离法等,例如在中国发明专利, CN 101050053 B中,介绍了有机泡沫浸渍法制备的骨支架,。这些方法均是试图借助材料组织本身来搭建支架结构的,而且由这些传统方法得到的支架强度普遍偏低,承重能力无法与真正的骨相匹配。另一方面支架材料要求其必须能够促进组织的再生,而组织再生的能力会受材料表面的性状与细胞的相互作用,和支架的物质传导作用的影响。 As a temporary structure for the growth of cells, the scaffold is a place that can induce cell differentiation and regenerate tissues and organs similar to the shape of the scaffold, and plays an important role in bone tissue engineering. The biggest feature of bone tissue is that the intercellular matrix has a large amount of calcium salt deposition, forming one of the hardest tissues in the human body. Structurally, hydroxyapatite can be regarded as a compressed material. For scaffold materials in bone tissue engineering, the primary requirement is the mechanical properties, that is, the mechanical properties of the scaffold must match those of the environmental tissue: low-strength scaffolds are not enough to support the daily activities of the human body. At present, the methods for preparing scaffolds mainly include organic foam impregnation method, pore-forming agent method, gas foaming method, and heat-induced phase separation method. For example, in the Chinese invention patent, CN 101050053 B, the bone scaffold prepared by organic foam impregnation method is introduced ,. These methods all try to use the material tissue itself to build a scaffold structure, and the strength of the scaffold obtained by these traditional methods is generally low, and the load-bearing capacity cannot match the real bone. On the other hand, the scaffold material requires that it must be able to promote tissue regeneration, and the ability of tissue regeneration will be affected by the interaction between the properties of the material surface and cells, and the substance conduction of the scaffold.
在近些年来一种新型骨组织材料受到越来越多的关注,它就是硼酸盐生物玻璃。它具有很好的生物活性,在生物玻璃、软组织和骨之间存在着密切的离子交换,从而导致材料界面与人体骨组织之间形成化学键合,表面能够生成具有生物活性的羟基磷灰石层,随着时间的延长可以完全降解。但是,由于传统制备方法得到的支架强度问题,生物玻璃支架难以作为承重部位的植入材料应用。 In recent years, a new type of bone tissue material has received more and more attention, which is borate bioglass. It has good biological activity, and there is a close ion exchange between the biological glass, soft tissue and bone, which leads to the formation of chemical bonds between the material interface and human bone tissue, and the surface can generate a biologically active hydroxyapatite layer , can be completely degraded with time. However, due to the strength problem of the scaffold obtained by the traditional preparation method, it is difficult to apply the bioglass scaffold as an implant material in the load-bearing part.
建立在已有的一种可控降解性能的玻璃支架制备的基础(中国发明专利, CN 101050053 B和中国发明专利, CN 101125218 B)上,本专利申请描述了一种有规则孔分布的生物玻璃高强度骨支架及其制备方法,与之前的工艺方法相比,本专利制备出的支架强度提高一个数量级,且具有孔分布规则、连通的特点。在本专利中规定了硼酸盐生物玻璃支架的组成;三维打印技术的具体实现方法;打印浆料的制备方法;对支架进行了细胞实验和动物实验。结果表明这种硼酸盐玻璃支架在烧结过程中不析晶,仍保持原有的玻璃相物态,具有良好的加工性能;由于具有均匀的孔分布,坯体烧结时各方向收缩程度一致,因此不会改变孔结构;与传统方法相比该支架抗压强度大大提高;此外,通过细胞实验和动物实验证实了这种方法制备的骨组织工程支架有良好的生物相容、降解性和刺激骨细胞生长的性能。 Based on the existing preparation of a glass bracket with controllable degradation performance (Chinese invention patent, CN 101050053 B and Chinese invention patent, CN 101125218 B), this patent application describes a bioglass with regular pore distribution The high-strength bone scaffold and its preparation method, compared with the previous process, the strength of the scaffold prepared by this patent is increased by an order of magnitude, and has the characteristics of regular distribution and connectivity of pores. In this patent, the composition of the borate bioglass support; the specific implementation method of the three-dimensional printing technology; the preparation method of the printing paste; the cell experiment and the animal experiment on the support are specified. The results show that the borate glass support does not devitrify during the sintering process, and still maintains the original glass phase state, and has good processing performance; due to the uniform pore distribution, the green body shrinks in all directions during sintering. Therefore, the pore structure will not be changed; compared with the traditional method, the compressive strength of the scaffold is greatly improved; in addition, it has been confirmed through cell experiments and animal experiments that the bone tissue engineering scaffold prepared by this method has good biocompatibility, degradability and stimulation Growth properties of bone cells.
发明内容 Contents of the invention
本发明的目的在于提供一种有规则孔分布的高强度生物玻璃骨支架的制备方法,解决浆料不能适应快速成形的问题,和传统方法制备的支架的生物活性不够高,或者抗压强度不够高的缺点。 The purpose of the present invention is to provide a method for preparing a high-strength bioglass bone scaffold with regular pore distribution, which solves the problem that the slurry cannot be adapted to rapid prototyping, and the bioactivity of the scaffold prepared by the traditional method is not high enough, or the compressive strength is not enough High disadvantage.
本发明提出的有规则孔分布的高强度生物玻璃骨支架的制备方法,利用三维打印技术将特制的硼酸盐生物玻璃浆料打印(挤出)堆积成支架前驱体(蜂窝状坯体),最后烧结成具有规则孔结构的高强度生物玻璃支架。这种支架不仅在生理模拟液中可以逐渐被降解,有良好的生物相容性和生物活性,对成骨有刺激作用;而且有较高的机械性能,在临床上对节段性骨修复有潜在的应用。具体步骤如下: The preparation method of the high-strength bioglass bone scaffold with regular pore distribution proposed by the present invention uses three-dimensional printing technology to print (extrude) the special borate bioglass paste and accumulate it into a scaffold precursor (honeycomb green body), Finally, it is sintered into a high-strength bioglass scaffold with regular pore structure. This kind of scaffold can not only be gradually degraded in physiological simulated fluid, but also has good biocompatibility and biological activity, and has a stimulating effect on osteogenesis; it also has high mechanical properties, which is beneficial to segmental bone repair in clinical practice. potential applications. Specific steps are as follows:
(1)玻璃粉料的制备 (1) Preparation of glass powder
用于支架制备的生物玻璃是以硼酸盐为主体的硼硅酸盐体系玻璃,生物玻璃粉料的组成为:以B2O3 或P2O5为玻璃网络主体或兼含SiO2的含钙玻璃,总摩尔比为30-90 mol%,玻璃的网络外体含有CaO,并还含有Na2O、K2O碱金属氧化物以及MgO,SrO碱土金属氧化物或稀土金属氧化物;网络外体离子氧化物的总摩尔比例占玻璃组成总摩尔量为5-80mol%,其中碱土金属氧化物的摩尔含量占总摩尔量为5-60mol%;根据上述玻璃的组成与配比,取与金属氧化物相应的氧化物、氯化物、碳酸盐、硫酸盐和磷酸盐的工业原料作为玻璃配合料,混合均匀,在1000-1400℃下熔融玻璃并保温0.5-8小时;随后淬冷得到玻璃块。将所得玻璃块依次经横式球磨机粗碎、行星球磨机细碎或气流粉碎机细碎,并筛分得到最终粒径为0.05-50μm的玻璃粉料; The bioglass used for the preparation of the scaffold is a borosilicate system glass with borate as the main body. The composition of the bioglass powder is: B 2 O 3 or P 2 O 5 as the main body of the glass network or SiO 2 Calcium-containing glass, the total molar ratio is 30-90 mol%, and the outer body of the glass contains CaO, and also contains Na 2 O, K 2 O alkali metal oxides and MgO, SrO alkaline earth metal oxides or rare earth metal oxides; The total molar ratio of ion oxides outside the network accounts for 5-80mol% of the total molar weight of the glass composition, and the molar content of alkaline earth metal oxides accounts for 5-60 molar% of the total molar weight; according to the composition and proportion of the above glass, take The industrial raw materials of oxides, chlorides, carbonates, sulfates and phosphates corresponding to metal oxides are used as glass batch materials, mixed evenly, and the glass is melted at 1000-1400 ° C and kept for 0.5-8 hours; then quenched Get glass blocks. The obtained glass blocks are coarsely crushed by a horizontal ball mill, finely crushed by a planetary ball mill or finely crushed by a jet mill, and sieved to obtain glass powder with a final particle size of 0.05-50 μm;
(2)丙二醇嵌段聚醚有机调和液的制备 (2) Preparation of propylene glycol block polyether organic blending solution
丙二醇嵌段聚醚是由聚醚(分子量为1800-2500)和2,6-二叔丁基对甲酚(纯度大于98%)通过亲核取代反应而合成的。前者分子式为HO.(C2H4O)m.(C3H6O)n.H,后者为C15H24O。将两者以1:1-2.5:1的重量比率混合成悬液浊液,用50wt%的甲苯溶液,溶解此悬浊液,置于三口烧瓶中。用铂氯酸(H2PtCl6·6H2O)的异丙醇溶液(浓度为0.01mol/L)作为催化剂,催化剂的用量为50ug/g(催化剂重量/反应物重量),在70-90℃温度下,激烈搅拌,冷凝回流,氮气保护,反应5-8小时后,取出反应物,通过减压蒸馏,除去单体和低聚合物,获得粘稠的丙二醇嵌段聚醚。将合成的丙二醇嵌段聚醚(克),溶解在50%乙醇(毫升)中,比例为1:0.5-1:1.5制得溶液,就得到所需的有机调和液。用粘度法表征有机调和液的相变温度在20-40℃之间。因为我们需要的浆料在低温时呈溶胶状,有一定流动性,高于相转变温度则立即固化。本实验的相变温度在室温附近,有利于控制相变发生,即该相变温度有利于合成支架坯体。 Propylene glycol block polyether is synthesized by nucleophilic substitution reaction of polyether (molecular weight 1800-2500) and 2,6-di-tert-butyl-p-cresol (purity greater than 98%). The molecular formula of the former is HO.(C 2 H 4 O)m.(C 3 H 6 O)nH, and the latter is C 15 H 24 O. Mix the two at a weight ratio of 1:1-2.5:1 to form a suspension, dissolve the suspension with 50wt% toluene solution, and place it in a three-necked flask. Platinum chloric acid (H 2 PtCl 6 6H 2 O) isopropanol solution (concentration: 0.01mol/L) is used as the catalyst, the amount of the catalyst is 50ug/g (catalyst weight/reactant weight), at 70-90 Stir vigorously at ℃, condense and reflux, and protect with nitrogen. After reacting for 5-8 hours, take out the reactants, remove monomers and low polymers through vacuum distillation, and obtain viscous propylene glycol block polyether. Dissolve the synthesized propylene glycol block polyether (g) in 50% ethanol (mL) at a ratio of 1:0.5-1:1.5 to prepare a solution to obtain the desired organic blend. The phase transition temperature of the organic blend liquid characterized by viscosity method is between 20-40°C. Because the slurry we need is in the form of a sol at low temperature, has a certain fluidity, and solidifies immediately above the phase transition temperature. The phase transition temperature in this experiment is around room temperature, which is beneficial to control the occurrence of phase transition, that is, the phase transition temperature is conducive to the synthesis of the stent blank.
(3)玻璃料浆的制备 (3) Preparation of glass slurry
将所得的玻璃粉料以一定比例与上述调和液混合,混合的比例(即玻璃粉重量(克): 调和液体积(毫升))为1: 0.1-1: 0. 5;经激烈搅拌4-8小时后置于10℃-20℃水浴中存放以去除气泡,制成均匀的玻璃料浆。最后放入冰箱中陈化4小时后待用。 Mix the obtained glass powder with the above-mentioned blending liquid in a certain proportion, and the mixing ratio (ie glass powder weight (g): blending liquid volume (ml)) is 1: 0.1-1: 0.5; after vigorous stirring 4- After 8 hours, store it in a water bath at 10°C-20°C to remove air bubbles and make a uniform glass slurry. Finally put it in the refrigerator to age for 4 hours before use.
(4)蜂窝状坯体的制备 (4) Preparation of honeycomb green body
先将浆料用10-225μm的筛子过筛,去除大块团聚,并将过筛后的浆料灌入打印机的注(喷)射器中,浆料会通过注射口直径尺寸为0.2-2毫米可调节的注(喷)射器,在0.01-0.05MPa压力下自注射口(喷头)挤出,挤出速度为0.05-1.0毫米/秒,构成连续成线状的浆体柱。打印过程中喷管及挤出的料浆均位于40℃-70℃的油浴中(99%煤油),以便打印出的料浆能够迅速固化成固体柱,这样不仅可以保证打印出的坯体形状规则,还可以立即承受随后加于其上的固体柱的重量。挤压出的第一层料浆平铺在Al2O3板上,随后的料浆自下而上逐层累积,固化成由固体柱构成的蜂窝状坯体。坯体制备过程均由电脑程序预先设计,并全程控制挤出浆料的速度,以适应料浆粘结下层固体柱的凝固时间;全程控制挤出的位置,以调节由固体柱形成的上下、左右和高低的三维孔隙,构成不同的孔隙率和孔径的蜂窝状坯体。 First sieve the slurry with a 10-225μm sieve to remove large agglomerates, and pour the sieved slurry into the injection (jet) injector of the printer, and the slurry will pass through the injection port with a diameter of 0.2-2 The millimeter-adjustable injection (jet) injector is extruded from the injection port (nozzle) under the pressure of 0.01-0.05MPa, and the extrusion speed is 0.05-1.0mm/s to form a continuous linear slurry column. During the printing process, the nozzle and the extruded slurry are located in an oil bath (99% kerosene) at 40°C-70°C, so that the printed slurry can quickly solidify into a solid column, which not only ensures that the printed blank Regular in shape, it also immediately bears the weight of a solid column subsequently added to it. The extruded first layer of slurry is flatly spread on the Al 2 O 3 plate, and the subsequent slurry is accumulated layer by layer from bottom to top, and solidified into a honeycomb green body composed of solid columns. The green body preparation process is pre-designed by computer programs, and the speed of extruding slurry is controlled throughout the process to adapt to the solidification time of the solid column bonded by the slurry; the position of extrusion is controlled throughout the process to adjust the up and down, The three-dimensional pores of left, right and high and low constitute honeycomb blanks with different porosity and pore diameter.
(5)蜂窝状坯体的烧结 (5) Sintering of honeycomb body
支架坯体先放入10-90℃的烘箱中保温12-48小时去除大部分煤油。然后放入马弗炉中脱胶并烧结,其烧结条件为:以1℃/min升温速度升到400-550℃,保温5-24小时;以1℃/min升温速度升到550-700℃,保温1-5小时。 The stent body is first put into an oven at 10-90°C and kept warm for 12-48 hours to remove most of the kerosene. Then put it into a muffle furnace for degumming and sintering. The sintering conditions are: increase the temperature at 1°C/min to 400-550°C and keep it for 5-24 hours; increase the temperature at 1°C/min to 550-700°C. Keep warm for 1-5 hours.
利用本发明所获得支架能应用于节段性骨修复,能用作骨组织工程中骨支架材料,能完全降解形成新骨。 The scaffold obtained by using the invention can be applied to segmental bone repair, can be used as a bone scaffold material in bone tissue engineering, and can be completely degraded to form new bone.
利用本发明方法制备得到的玻璃支架有较好生物相容性,能黏附成骨细胞;有较好生物活性,玻璃支架降解后能转化成骨的无机成分羟基磷灰石;有优良的生物降解性,在生物体内完全降解。所得玻璃支架孔隙规则,孔隙率为10-95%,最大孔径尺寸为10-1000μm,抗压强度为30-70 MPa,较传统方法制备普遍得到的支架抗压强度高。并且由于三维打印法本身的特点,是按照预先已经设计好的三维外形软件来挤出浆料的,也就能对支架的结构和性能进行预设计,满足不同部位骨修复的需要。 The glass support prepared by the method of the present invention has better biocompatibility and can adhere to osteoblasts; has better biological activity, and can be transformed into hydroxyapatite, an inorganic component of bone after the glass support is degraded; has excellent biodegradation Sex, completely degraded in vivo. The obtained glass bracket has regular pores, a porosity of 10-95%, a maximum pore size of 10-1000 μm, and a compressive strength of 30-70 MPa, which is higher than that of commonly obtained brackets prepared by traditional methods. And because of the characteristics of the 3D printing method itself, the slurry is extruded according to the pre-designed 3D shape software, and the structure and performance of the scaffold can be pre-designed to meet the needs of different parts of bone repair.
附图说明 Description of drawings
图1为支架各方向形貌图:(a)立体图,(b)俯视图,(c)侧视图。 Figure 1 shows the topography of the bracket in various directions: (a) perspective view, (b) top view, (c) side view.
图2为丙二醇嵌段聚醚的相转变温度测定。 Figure 2 is the determination of the phase transition temperature of propylene glycol block polyether.
图3为支架抗压强度曲线。 Figure 3 is the compressive strength curve of the stent.
图4为玻璃粉和制备后支架的物相XRD测定。 Fig. 4 is the phase XRD measurement of the glass powder and the prepared support.
图5为支架样品浸泡20天后的XRD图谱。 Figure 5 is the XRD pattern of the scaffold sample soaked for 20 days.
图6为支架样品浸泡20天后的FTIR图谱。 Figure 6 is the FTIR spectrum of the stent sample soaked for 20 days.
图7为成骨细胞MC3T3-E1在37℃条件下在支架形貌以及其上的细胞黏附情况。其中:(a)浸泡3天后支架形貌,(b)5天后细胞黏附,(c) 9天后细胞黏附。 Figure 7 shows the morphology of osteoblast MC3T3-E1 on the scaffold and the cell adhesion on it at 37°C. Among them: (a) scaffold morphology after soaking for 3 days, (b) cell adhesion after 5 days, (c) cell adhesion after 9 days.
图8为节段性骨缺损处实施埋入支架实验后的X射线片。(a)4周,(b)8周,(c)12周。 Fig. 8 is the X-ray film of the segmental bone defect after the stent embedding experiment. (a) 4 weeks, (b) 8 weeks, (c) 12 weeks.
具体实施方式 Detailed ways
下面通过实施例进一步说明本发明。 The present invention is further illustrated below by way of examples.
实施例1:三维连通支架的制备,由下列五个步骤组成。 Example 1: The preparation of a three-dimensional connected scaffold consists of the following five steps.
(1)玻璃粉料的制备 (1) Preparation of glass powder
称取称取3.8185g无水碳酸钠,9.9587g无水碳酸钾,1.7502g碱式碳酸镁,19.8328g碳酸钙,7.9781g碳酸锶,9.7420g二氧化硅,41.2991g硼酸,5.6206g磷酸二氢钠。混合均匀并研磨后将配料置于铂金坩埚内在1200℃中保温30 min;随后将得到的玻璃液浇在钢板上淬冷得到玻璃块。将所得玻璃块依次经横式球磨机粗碎、球磨细碎并过筛得到最终粒径为0.05-5μm的玻璃粉料。 Weigh and weigh 3.8185g anhydrous sodium carbonate, 9.9587g anhydrous potassium carbonate, 1.7502g basic magnesium carbonate, 19.8328g calcium carbonate, 7.9781g strontium carbonate, 9.7420g silicon dioxide, 41.2991g boric acid, 5.6206g dihydrogen phosphate sodium. After mixing evenly and grinding, the ingredients were placed in a platinum crucible and kept at 1200 °C for 30 min; then the obtained glass liquid was poured on a steel plate and quenched to obtain a glass block. The obtained glass blocks are coarsely crushed by a horizontal ball mill, finely crushed by a ball mill and sieved to obtain glass powder with a final particle size of 0.05-5 μm.
(2)丙二醇嵌段聚醚有机调和液的制备和相转变温度的测定 (2) Preparation of propylene glycol block polyether organic compound solution and determination of phase transition temperature
取50ml的甲苯溶液(50wt%),置于三口烧瓶中。再称取聚丙二醇醚(分子量为2200)15克,另称取2,6-二叔丁基对甲酚(纯度大于98%)10克,两者充分混合成均匀的悬浊液,滴加到三口烧瓶中。再取铂氯酸(H2PtCl6·6H2O)的异丙醇溶液(浓度为0.01mol/L)1.25毫克,作为催化剂,滴加到三口烧瓶中。在90℃温度下,激烈搅拌,冷凝回流,氮气保护,反应5小时后,取出反应物,通过减压蒸馏,获得粘稠的丙二醇嵌段聚醚。 Take 50ml of toluene solution (50wt%) and place it in a three-necked flask. Then weigh 15 grams of polypropylene glycol ether (molecular weight: 2200), and weigh another 10 grams of 2,6-di-tert-butyl-p-cresol (purity greater than 98%). The two are fully mixed to form a uniform suspension, and added dropwise into a three-neck flask. Then take 1.25 mg of isopropanol solution (concentration: 0.01 mol/L) of platinum chloric acid (H 2 PtCl 6 ·6H 2 O) as a catalyst, and add it dropwise into the three-necked flask. Stir vigorously at a temperature of 90°C, condense and reflux, and protect with nitrogen. After reacting for 5 hours, take out the reactants and distill under reduced pressure to obtain viscous propylene glycol block polyether.
将粘稠的丙二醇嵌段聚醚用30毫升50%乙醇溶解,得到所需的有机调和液。用粘度法表征有机调和液在不同温度下的粘度突变点,确定相变温度为27℃(见图2)。 Dissolve the viscous propylene glycol block polyether with 30 milliliters of 50% ethanol to obtain the desired organic blend. Viscosity method was used to characterize the sudden change point of viscosity of organic blending liquid at different temperatures, and the phase transition temperature was determined to be 27°C (see Figure 2).
(3)玻璃料浆的制备 (3) Preparation of glass slurry
称取5g上述玻璃粉,加进2 ml有机调和液溶液,置于烧杯中搅拌均匀,使玻璃粉料均匀分散在调合液溶液中。然后再将其置于10℃水浴中去除气泡,制成均匀的料浆,放到4℃冰箱中,冷藏12小时后使用。 Weigh 5g of the above-mentioned glass powder, add 2ml of organic blending liquid solution, place in a beaker and stir evenly, so that the glass powder is evenly dispersed in the blending liquid solution. Then put it in a 10°C water bath to remove air bubbles, make a uniform slurry, put it in a 4°C refrigerator, and refrigerate for 12 hours before use.
(4)蜂窝状坯体的制备 (4) Preparation of honeycomb green body
先将料浆用75μm的筛子过筛,去除大块团聚,然后将过筛的料浆放入三维打印机针管中。打印过程中针管及挤出的料浆均位于40℃的油浴中(99%煤油)。油浴锅内放入Al2O3板,将打印喷头置于在Al2O3板之上,开启计算机打印程序,打印机喷口挤出蜂窝状坯体堆积在Al2O3板上。 First, sieve the slurry with a 75 μm sieve to remove large agglomerates, and then put the sieved slurry into the needle tube of the 3D printer. During the printing process, the needle tube and the extruded slurry were located in an oil bath (99% kerosene) at 40 °C. Put the Al 2 O 3 plate in the oil bath, place the printing nozzle on the Al 2 O 3 plate, start the computer printing program, and extrude the honeycomb green body from the nozzle of the printer to accumulate on the Al 2 O 3 plate.
(5)蜂窝状坯体的烧结 (5) Sintering of honeycomb body
将蜂窝状坯体放入30℃的烘箱中保温24小时去除大部分煤油, 然后放入马弗炉中脱胶并烧结,其烧结制度为:以1℃/min升温速度升到500℃,保温12小时;以1℃/min升温速度升到600℃,保温1小时,然后关闭电源,24小时后,炉温降至室温,蜂窝状坯体被烧结成支架。 Put the honeycomb body in an oven at 30°C for 24 hours to remove most of the kerosene, then put it in a muffle furnace for degumming and sintering. Hours; raise the temperature to 600°C at a rate of 1°C/min, keep it warm for 1 hour, and then turn off the power. After 24 hours, the furnace temperature drops to room temperature, and the honeycomb green body is sintered into a bracket.
通过上述各步骤,制备成具有规则孔结构的高强度生物玻璃支架(见图1A,1B和1C)。 Through the above steps, a high-strength bioglass scaffold with a regular pore structure was prepared (see Figures 1A, 1B and 1C).
实施例2:支架的孔径、孔隙率的测定和强度的测定 Embodiment 2: the mensuration of the aperture of support, porosity and the mensuration of intensity
按实施例1所叙述的方法,制备三维连通支架。参照国家标准GBT 5164-1985《可渗性烧结金属材料开孔率的测定》,对支架的孔隙率进行测定,结果表明该支架孔隙率为60%,最大孔径尺寸为400μm,与图1B和C的SEM的观察相符合。利用抗压强度测定仪测得实施例1中的支架抗压强度为30MPa(见图3)。 According to the method described in Example 1, a three-dimensional connected scaffold was prepared. Referring to the national standard GBT 5164-1985 "Determination of Porosity of Permeable Sintered Metal Materials", the porosity of the scaffold was measured, and the results showed that the porosity of the scaffold was 60%, and the maximum pore size was 400 μm, as shown in Figure 1B and C consistent with the SEM observations. The compressive strength of the bracket in Example 1 was measured by a compressive strength tester to be 30 MPa (see FIG. 3 ).
实施例3:生物性能的测定: Embodiment 3: the mensuration of biological property:
按实施例1所叙述的方法,制备三维连通支架。对制得的支架进行生物活性、生物降解性和生物相容性的测试。 According to the method described in Example 1, a three-dimensional connected scaffold was prepared. The bioactivity, biodegradability and biocompatibility tests were carried out on the prepared scaffold.
对制得的支架作XRD分析,并与玻璃粉作比较(见图4),说明经过一系列的热加工,获得的支架仍为玻璃相。然后对此支架在温度为37℃的生理模拟液中作浸泡实验,20天后取出支架,通过XRD和FTIR对反应过程和反应后产物进行表征(见图5、和6 ),产物XRD谱显示为典型的羟基磷灰石晶体的图谱, 产物的FTIR谱显示为典型的羟基磷灰石的红外图谱。结果表明:该硼酸盐玻璃生物活性支架样品在体外生物矿化反应中能转化为含锶羟基磷灰石,具有很好的生物活性和降解性。 XRD analysis was carried out on the obtained scaffold and compared with glass powder (see Figure 4), which indicated that after a series of thermal processing, the obtained scaffold was still in the glass phase. Then the stent was soaked in a physiological simulation solution at a temperature of 37°C. After 20 days, the stent was taken out, and the reaction process and post-reaction products were characterized by XRD and FTIR (see Figures 5 and 6). The XRD spectrum of the product was shown as The spectrum of a typical hydroxyapatite crystal, and the FTIR spectrum of the product is shown as a typical infrared spectrum of hydroxyapatite. The results show that the borate glass bioactive scaffold sample can be converted into strontium-containing hydroxyapatite in the in vitro biomineralization reaction, and has good bioactivity and degradability.
为了考察制备的支架与成骨细胞的生物相容性和细胞黏附性,将制得的支架放入盛有MC3T3-E1成骨细胞培养液的培养皿中分别培养3,5和9天,取出支架,用戊二醛固定后,再放入乙醇中萃去除水分并冷冻干燥。SEM显示,支架上有大量的细胞黏爬行(见图7),说明该支架很好有生物相容性和细胞黏附性。 In order to investigate the biocompatibility and cell adhesion of the prepared scaffolds and osteoblasts, the prepared scaffolds were placed in culture dishes filled with MC3T3-E1 osteoblast culture medium for 3, 5 and 9 days, and then removed. Scaffolds were fixed with glutaraldehyde, extracted with ethanol to remove water and freeze-dried. SEM showed that a large number of cells crawled on the scaffold (see Figure 7), indicating that the scaffold had good biocompatibility and cell adhesion.
实施例4:支架的动物实验: Embodiment 4: the animal experiment of scaffold:
按实施例1所叙述的方法,制备三维连通支架。对制得的支架进行动物实验的测试。 According to the method described in Example 1, a three-dimensional connected scaffold was prepared. Animal experiments were carried out on the prepared scaffolds.
将新西兰大白兔的双侧桡骨中段制成15mm节段性骨缺损,埋入实施例1制备的支架,图8为节段性骨缺损实验X射线片。术后4,8,12周通过X射线摄片观察骨生长情况,可以看出,植入4周后支架材料和骨直接结合; 8周后支架材料密度降低,材料两端和骨基本融合;12周后材料完全降解、骨生成明显,骨塑形基本完成。说明制得的支架对动物的骨缺损有很好的修复作用。 A 15 mm segmental bone defect was made in the middle part of the bilateral radius of New Zealand white rabbits, and the scaffold prepared in Example 1 was embedded. Fig. 8 is an experimental X-ray film of the segmental bone defect. After 4, 8, and 12 weeks, the bone growth was observed by X-ray film. It can be seen that after 4 weeks of implantation, the scaffold material is directly combined with the bone; after 8 weeks, the density of the scaffold material decreases, and the two ends of the material are basically fused with the bone; After 12 weeks, the material was completely degraded, bone formation was obvious, and bone shaping was basically completed. It shows that the prepared scaffold has a good repairing effect on the bone defect of animals.
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201210026907 CN102526797B (en) | 2012-02-08 | 2012-02-08 | Preparation method of high-strength biological glass bone bracket with regular-hole distribution |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201210026907 CN102526797B (en) | 2012-02-08 | 2012-02-08 | Preparation method of high-strength biological glass bone bracket with regular-hole distribution |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102526797A CN102526797A (en) | 2012-07-04 |
CN102526797B true CN102526797B (en) | 2013-10-30 |
Family
ID=46335602
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201210026907 Expired - Fee Related CN102526797B (en) | 2012-02-08 | 2012-02-08 | Preparation method of high-strength biological glass bone bracket with regular-hole distribution |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102526797B (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103073174A (en) * | 2013-02-19 | 2013-05-01 | 苏州百纳思光学科技有限公司 | 3D laser printing device taking low-melting-point glass powder as raw material |
CN104117090B (en) * | 2013-04-24 | 2016-08-10 | 上海交通大学医学院附属第九人民医院 | Mesoporous bioglass porous support of labelled with radioisotope and preparation method thereof |
CN103896495A (en) * | 2014-02-27 | 2014-07-02 | 同济大学 | Method for preparing antibacterial borate glass bracket |
CN103893811B (en) * | 2014-03-14 | 2015-12-30 | 同济大学 | The application of a kind of preparation method of bio-vitric felt and products thereof |
CN105879122B (en) * | 2016-04-28 | 2019-10-18 | 广东工业大学 | Degradable bioactive ceramic/metal composite material and its preparation method and application |
US10647962B2 (en) * | 2016-05-27 | 2020-05-12 | Corning Incorporated | Bioactive aluminoborate glasses |
US20170342383A1 (en) | 2016-05-27 | 2017-11-30 | Corning Incorporated | Lithium disilicate glass-ceramic compositions and methods thereof |
CN111417603B (en) | 2017-11-28 | 2023-10-31 | 康宁股份有限公司 | Bioactive borate glass and method thereof |
CN111405913A (en) | 2017-11-28 | 2020-07-10 | 康宁股份有限公司 | Bioactive glass compositions and dentinal hypersensitivity repair |
US10857259B2 (en) | 2017-11-28 | 2020-12-08 | Corning Incorporated | Chemically strengthened bioactive glass-ceramics |
EP3717427A1 (en) | 2017-11-28 | 2020-10-07 | Corning Incorporated | High liquidus viscosity bioactive glass |
CN109550071B (en) * | 2018-12-05 | 2021-08-24 | 中国科学院深圳先进技术研究院 | Polyurethane sponge material and its preparation method, application and polyurethane sponge product |
CN109663147B (en) * | 2019-02-19 | 2022-07-05 | 邢叔星 | A kind of PEEK bone graft attached with tricalcium phosphate sustained-release antibiotic and preparation method thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002074353A1 (en) * | 2001-03-16 | 2002-09-26 | Vivoxid Oy | Sintering of bioactive glass with localised electromagnetic and/or acoustic energy |
EP1914209A1 (en) * | 2006-10-18 | 2008-04-23 | Degussa Novara Technology S.p.A. | New process of making biomaterials |
CN101259277B (en) * | 2008-04-25 | 2012-07-25 | 同济大学 | Novel orthopaedics medicaments carrier system and preparation thereof |
CN102247599A (en) * | 2010-05-19 | 2011-11-23 | 上海市第六人民医院 | Slow release system for borate bioglass carried with antibiotic and preparation method thereof |
-
2012
- 2012-02-08 CN CN 201210026907 patent/CN102526797B/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN102526797A (en) | 2012-07-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102526797B (en) | Preparation method of high-strength biological glass bone bracket with regular-hole distribution | |
Baino et al. | Bioactive sol‐gel glasses: processing, properties, and applications | |
CN105582571B (en) | A kind of bioactivity, porous support manufacturing method of high intensity | |
Kaur et al. | Review and the state of the art: sol–gel and melt quenched bioactive glasses for tissue engineering | |
CN105769382B (en) | It is adapted to bioactivity, porous structure stand and its manufacture method that osteanagenesis is repaired | |
Jones et al. | Controlling ion release from bioactive glass foam scaffolds with antibacterial properties | |
Li et al. | Hierarchically porous bioactive glass scaffolds synthesized with a PUF and P123 cotemplated approach | |
US20110144765A1 (en) | Process For Producing Porous Scaffolds From Sinterable Glass | |
CN1323986C (en) | Method for preparing CaO-P2O5-MgO glass reinforced porous beta-tricalcium phosphate bioceramics | |
US10149920B2 (en) | Implant with controlled porosity made of a hybrid material | |
RU2005140093A (en) | INORGANIC REBORABLE BONE REPLACEMENT MATERIAL | |
CN106999633A (en) | The transformable hybrid material implant of porosity | |
Palivela et al. | Extrusion-based 3D printing of bioactive glass scaffolds-process parameters and mechanical properties: A review | |
Ben–Arfa et al. | Robocasting of Cu2+ & La3+ doped sol–gel glass scaffolds with greatly enhanced mechanical properties: compressive strength up to 14 MPa | |
Zhang et al. | Digital light processing of β-tricalcium phosphate bioceramic scaffolds with controllable porous structures for patient specific craniomaxillofacial bone reconstruction | |
CN101050053B (en) | Method for preparing engineering material of bone tissue and application | |
Roozbahani et al. | Dexamethasone loaded Laponite®/porous calcium phosphate cement for treatment of bone defects | |
CN101091805A (en) | Lumpish biologic bracket material with diplopore and preparation method | |
CN100591365C (en) | Inorganic resorbable bone substitute material | |
Hupa et al. | Bioactive Glasses | |
Chatzistavrou et al. | Bioactive glass and glass-ceramic scaffolds for bone tissue engineering | |
Fiume et al. | Robocasting of mesoporous bioactive glasses (MBGs) for bone tissue engineering | |
KR101280891B1 (en) | Method of preparation of a bone chip for bone tissue regeneration and a bone chip for bone tissue regeneration made by the same | |
Baino et al. | Glasses and glass–ceramics for biomedical applications | |
Moawad et al. | Fabrication of nano-macroporous glass–ceramic bioscaffold with a water soluble pore former |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20131030 Termination date: 20160208 |